Clinical Trials

BreastGastrointestinalSarcomaThoracic

Breast Neoplasms, Carcinoma, Liver Neoplasms, Lung Neoplasms, Pancreatic Neoplasms, Sarcoma, Stomach Neoplasms, Colorectal Neoplasms

NCT05851456 2023-05-09

A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Bone and Soft Tissue Tumors

Sarcoma

Bone Neoplasms, Sarcoma, Osteosarcoma

NCT05830240 2023-04-26

A Clinical Study on Oncolytic Virus Injection (R130 OV) for the Treatment of Relapsed/Refractory Head and Neck Cancer

GastrointestinalHead & Neck

Ear Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Laryngeal Neoplasms, Nose Neoplasms, Otorhinolaryngologic Neoplasms, Pharyngeal Neoplasms

NCT05812677 2023-04-14

A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Cervical and Endometrial Cancer

Gynecologic

Uterine Cervical Neoplasms, Endometrial Neoplasms

NCT05801783 2023-04-06

A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Ovarian Cancer

Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms, Peritoneal Neoplasms

NCT05722171 2023-02-10

Clinical Study of UTAA06 Injection in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia

Leukemia, Myeloid, Acute

NCT05652530 2022-12-15

Clinical Study of the Safety and Efficacy of BCMA CAR-NK

19 enrolled

Multiple Myeloma

NCT05651191 2022-12-14

To Evaluate the Safety and Efficacy of Human CD19 Targeted DASH CAR-T Cells Injection for Subjects With R/R B-ALL

Burkitt Lymphoma

NCT03692663 2022-08-01

Study of Anti-PSMA CAR NK Cell (TABP EIC) in Metastatic Castration-Resistant Prostate Cancer

Genitourinary

Metastatic Castration-resistant Prostate Cancer

NCT05480501 2022-07-29

Clinical Trial to Evaluate the Safety and Efficacy of IM19 CAR-T Cells in Patients With Relapsed and Refractory (R/R) B-cell Acute Lymphoblastic Leukemia

LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Leukemia

NCT05478343 2022-07-28

Clinical Trial to Evaluate the Safety and Efficacy of IM21 CAR-T Cells in Patients With Relapsed and Refractory (R/R) Multiple Myeloma

Multiple Myeloma

NCT05432401 2022-06-27

TAA05 Injection in the Treatment of Adult Patients With FLT3-positive Relapsed/Refractory Acute Myeloid Leukemia

18 enrolled

Leukemia, Myeloid, Acute

NCT04721756 2022-04-25

Early Clinical Evaluation of 18F-LY3546117 in Tumor Imaging

30 enrolled

Tumor-Agnostic

Neoplasms

NCT05333588 2022-04-19

The Safety Study of Autologous TILs Therapy for Patients With Glioblastoma Multiforme.

CNS

Glioblastoma, Glioma

NCT05287165 2022-03-18

Clinical Trial to Evaluate the Safety and Efficacy of IM96 CAR-T Cells Therapy in Patients With Advanced Digestive System Neoplasms

19 enrolled

Gastrointestinal

Colonic Neoplasms, Digestive System Neoplasms

NCT05275062 2022-03-11

Clinical Trial to Evaluate the Safety and Efficacy of IM92 CAR-T Cells Therapy in Patients With Advanced Gastric or Pancreatic Adenocarcinoma

6 enrolled

Gastrointestinal

Pancreatic Neoplasms, Stomach Neoplasms

NCT03943472 2021-08-31

BCMA Chimeric Antigen Receptor Expressing T Cells Therapy for Relapsed/Refractory Multiple Myeloma

Multiple Myeloma

NCT04951141 2021-07-06

Clinical Study of Intratumoral Injection of CAR-T Cells in the Treatment of Advanced Liver Tumors

Gastrointestinal

Liver Neoplasms

NCT04919616 2021-06-09

An Exploratory Clinical Study of TILs in the Treatment of Recurrent / Refractory Non-small Cell Lung Cancer (NSCLC)

15 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT03795779 2021-05-19

CLL1-CD33 cCAR in Patients With Relapsed and/or Refractory, High Risk Hematologic Malignancies

MyeloidOther hematologic neoplasm

Leukemia, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Hematologic Neoplasms

NCT04864821 2021-05-06

Clinical Study of CD276 Targeted Autologous Chimeric Antigen Receptor T Cell Infusion in Patients With CD276 Positive Advanced Solid Tumor

CNSGastrointestinalSarcomaThoracic

24 enrolled

Lung Neoplasms, Neuroblastoma, Osteosarcoma, Stomach Neoplasms

NCT04841421 2021-04-12

Clinical Study on PET Imaging, Distribution and PK of 89Zr-CD147 in Patients With Solid Tumors

30 enrolled

Other solid neoplasm

Solid Tumor

NCT04803929 2021-03-23

Clinical Study of Anti-ILT3 CAR-T Therapy for R/R AML(M4/M5)

25 enrolled

Leukemia, Monocytic, Acute, Leukemia, Myelomonocytic, Acute

NCT04700319 2021-03-08

CAR-T CD19/CD20 for Patients With Advanced CD19/CD20+ B Cell Line Recurrent or Refractory Hematological Malignancies

30 enrolled

Hematologic Neoplasms

NCT04702841 2021-03-08

CAR - γ δ T Cells in the Treatment of Relapsed and Refractory CD7 Positive T Cell-derived Malignant Tumors

8 enrolled

Tumor-Agnostic

Neoplasms

NCT04691349 2021-01-11

CAR-T for r/r Malignant Tumors in Children

Tumor-Agnostic

Neoplasms

NCT04439721 2021-01-06

γδT

LymphoidOther hematologic neoplasm

5 enrolled

Leukemia, Leukemia, B-Cell

NCT04674488 2020-12-19

TILs for Treatment of Metastatic or Recurrent Cervical Cancer

15 enrolled

Gynecologic

Uterine Cervical Neoplasms, Neoplasm Metastasis

NCT04626726 2020-11-13

Adult B-ALL Treated by CART Cell Bridging Allogeneic Hematopoietic Stem Cell Transplantation

50 enrolled

Burkitt Lymphoma

NCT04626752 2020-11-13

CAR-T Cells in Treating Patients With Relapsed or Refractory Multiple Myeloma

50 enrolled

Multiple Myeloma, Recurrence

NCT04626765 2020-11-13

CAR-T for Children With Relapsed and Refractory Acute Lymphoblastic Leukemia

LymphoidOther hematologic neoplasm

50 enrolled

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04503980 2020-08-07

αPD1-MSLN-CAR T Cells for the Treatment of MSLN-positive Advanced Solid Tumors

GastrointestinalGynecologic

Ovarian Neoplasms, Colorectal Neoplasms

NCT04209712 2020-07-29

Natural Killer Cells Infusion for Treating Acute Myeloid Leukemia Patients With Minimal Residual Disease

6 enrolled

Leukemia, Myeloid, Acute

NCT03371992 2020-03-27

NO3DEXPL

25 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT03790891 2020-03-13

Treatment of Non-Hodgkin Lymphoma With CD19-TriCAR-T/SILK Cell Therapy

12 enrolled

Lymphoma, Non-Hodgkin

NCT04191941 2019-12-10

Treatment of Hematological Malignancy With Novel CAR-T Cells.

LymphoidPlasma cell

Burkitt Lymphoma, Multiple Myeloma, Lymphoma, B-Cell

NCT03649529 2019-12-06

Treatment of Malignant Melanoma With GPA-TriMAR-T Cell Therapy

6 enrolled

Dermatologic

Melanoma

NCT04186052 2019-12-04

Clinical Trial of BCMA CAR T Cell Infusion in Patients With BCMA-positive r/r Multiple Myeloma

Multiple Myeloma

NCT04184414 2019-12-03

The Clinical Application of Chimeric Antigen Receptor T Cells in the Treatment of CD19 Positive Recurrent Refractory B Cell-derived Hematological Malignancies